StreetInsider.com News Articles

Form 8-K MAINZ BIOMED N.V. For: Mar 17

Tue, 17 Mar 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260317/26171138.html

Form 8-K MAINZ BIOMED N.V. For: Mar 17

Tue, 17 Mar 2026 08:30:00 -0400

si-local-file:///var/storage/secattach/20260317/26171138.html

Form PRE 14A MAINZ BIOMED N.V. For: Mar 12

Thu, 12 Mar 2026 09:25:00 -0400

si-local-file:///var/storage/secattach/20260312/26150621.html

Form PRE 14A MAINZ BIOMED N.V. For: Mar 12

Thu, 12 Mar 2026 09:25:00 -0400

si-local-file:///var/storage/secattach/20260312/26150621.html

Form 8-K MAINZ BIOMED N.V. For: Mar 11

Wed, 11 Mar 2026 07:35:00 -0400

si-local-file:///var/storage/secattach/20260311/26142667.html

Form 8-K MAINZ BIOMED N.V. For: Mar 11

Wed, 11 Mar 2026 07:35:00 -0400

si-local-file:///var/storage/secattach/20260311/26142667.html

Mainz Biomed appoints Robert Liscouski as chairman, changes name to Quantum Cyber

Wed, 11 Mar 2026 07:30:08 -0400

Mainz Biomed N.V. (NASDAQ: MYNZ) announced the appointment of Robert P. Liscouski as Chairman of its Board of Directors. The molecular genetics diagnostic company also said it plans to change its name to Quantum Cyber and its Nasdaq ticker symbol to QUCY, beginning March 12, 2026.

The permanent election of Liscouski and the name change will become effective at the company's extraordinary general meeting planned for April 2026. The company will begin doing business as Quantum Cyber and trading under the symbol QUCY starting March 12, 2026.

Liscouski was appointed by President George W. Bush as the first Assistant Secretary for Infrastructure

Mainz Biomed appoints Robert Liscouski as chairman, changes name to Quantum Cyber

Wed, 11 Mar 2026 07:30:08 -0400

Liscouski was appointed by President George W. Bush as the first Assistant Secretary for Infrastructure

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Wed, 11 Mar 2026 07:30:00 -0400

Company Also Announces New Name: Quantum Cyber and Change in Nasdaq Ticker symbol

BERKELEY, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, today announced that Robert P. Liscouski has been appointed Chairman of its Board of Directors. Further, the Company announced that it plans to change its name to Quantum Cyber and change its Nasdaq ticker symbol to QUCY, beginning on March 12, 2026. The permanent election of Mr. Liscouski and the change of Company name will become effective at the Company’s extraordinary

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Wed, 11 Mar 2026 07:30:00 -0400

Company Also Announces New Name: Quantum Cyber and Change in Nasdaq Ticker symbol

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Wed, 11 Mar 2026 07:30:00 -0400

Company Also Announces New Name: Quantum Cyber and Change in Nasdaq Ticker symbol

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Wed, 11 Mar 2026 07:30:00 -0400

Company Also Announces New Name: Quantum Cyber and Change in Nasdaq Ticker symbol

Maxim Group Downgrades Mainz Biomed B.V. (MYNZ) to Hold

Fri, 06 Mar 2026 07:49:52 -0400

Maxim Group analyst Michael Okunewitch downgraded Mainz Biomed B.V. (NASDAQ: MYNZ) from Buy to Hold.

For an analyst ratings summary and ratings history on Mainz Biomed B.V. click here. For more ratings news on Mainz Biomed B.V. click here.

Shares of Mainz Biomed B.V. closed at $0.81 yesterday.

Form 4 MAINZ BIOMED N.V. For: Feb 13 Filed by: Lazar David E.

Tue, 03 Mar 2026 10:13:00 -0400

si-local-file:///var/storage/secattach/20260303/26098446.html

Form 4 MAINZ BIOMED N.V. For: Feb 13 Filed by: Lazar David E.

Tue, 03 Mar 2026 10:13:00 -0400

si-local-file:///var/storage/secattach/20260303/26098446.html

Form 3 MAINZ BIOMED N.V. For: Feb 13 Filed by: Lazar David E.

Tue, 03 Mar 2026 10:11:00 -0400

si-local-file:///var/storage/secattach/20260303/26098423.html

Form 3 MAINZ BIOMED N.V. For: Feb 13 Filed by: Lazar David E.

Tue, 03 Mar 2026 10:11:00 -0400

si-local-file:///var/storage/secattach/20260303/26098423.html

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples

Tue, 24 Feb 2026 07:30:00 -0400

Mainz Biomed to Present Industry Leading Results: 100% Sensitivity and 95% Specificity

BERKELEY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ: MYNZ), a molecular genetics diagnostic company specializing in the early detection of cancer, is excited to announce its participation in the renowned Digestive Disease Week (DDW) 2026 in Chicago, Illinois. At the conference the Company will present its poster titled “BLOOD-BASED MRNA SIGNATURE FOR DETECTION OF PANCREATIC DUCTAL ADENOCARCINOMA AND DISCRIMINATION OF INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS”.

“We are thrilled about the team’s progress in confirming the strong clinical results from our discovery study. What’s

Mainz Biomed to Present at the Pancreatic Cancer Session at Digestive Disease Week, Demonstrating Effectiveness of mRNA Biomarkers in Blood Samples

Tue, 24 Feb 2026 07:30:00 -0400

Mainz Biomed to Present Industry Leading Results: 100% Sensitivity and 95% Specificity

“We are thrilled about the team’s progress in confirming the strong clinical results from our discovery study. What’s

Form 4 MAINZ BIOMED N.V. For: Feb 13 Filed by: Dreismann Heinrich

Thu, 19 Feb 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260219/26031139.html

Form 4 MAINZ BIOMED N.V. For: Feb 13 Filed by: Dreismann Heinrich

Thu, 19 Feb 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260219/26031139.html

Form 4 MAINZ BIOMED N.V. For: Feb 13 Filed by: Caragol William J

Thu, 19 Feb 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260219/26031151.html

Form 4 MAINZ BIOMED N.V. For: Feb 13 Filed by: Caragol William J

Thu, 19 Feb 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260219/26031151.html

Form 4 MAINZ BIOMED N.V. For: Feb 13 Filed by: Tibbitts Gregory J

Thu, 19 Feb 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260219/26031133.html

Form 4 MAINZ BIOMED N.V. For: Feb 13 Filed by: Tibbitts Gregory J

Thu, 19 Feb 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260219/26031133.html